
MeAgain is the best Goby Meds alternative for GLP-1 users because it gives you a stronger daily app, clearer long-term self-pay math, and one place to run the whole week. Goby Meds is a real telehealth option with no monthly fee and cheaper starter pricing at about $99/month for compounded semaglutide and $133/month for compounded tirzepatide, but its pricing rises to about $169/month and $299/month as doses go up. MeAgain keeps compounded semaglutide at $123/month and compounded tirzepatide at $199/month at every dose, plus a monthly app subscription. Inside the 286,000-user app, you get a prep checklist, a weekly medication graph, side-effect logging across 20 symptoms, food logging, and the Capybara home screen widget. MeAgain is rated 4.8 stars across over 15,000 App Store ratings, and eligible subscribers can use the in-app intake and receive medication from US-based 503A and 503B pharmacies in 5–7 days.
Goby Meds is a real telehealth option with free 2-day cold-pack shipping, no monthly fee, and cheaper starter pricing. MeAgain takes a different path: a daily GLP-1 app plus flat pricing that stays the same as doses go up. Both companies offer compounded medication. The honest tradeoff is cheaper starter packs at Goby versus stronger daily tools and flatter long-term math at MeAgain.
| Feature | MeAgain | Goby Meds |
|---|---|---|
| GLP-1 daily tracking app (286K users) | ||
| Flat pricing at every dose tier | ||
| Shot day checklist with prep steps | ||
| Estimated medication levels chart | ||
| Injection site rotation tracking | ||
| Side effect tracking (severity slider, 20 symptoms) | ||
| Capybara home screen widget | ||
| Photo AI food logging | ||
| Compounded GLP-1 medication access | ||
| Licensed clinician consultation | ||
| 12-week pre-paid starter bundle option |

Goby Meds' public site shows a familiar telehealth flow: online intake, licensed clinician review, and refrigerated delivery. MeAgain adds the part many GLP-1 users still need after the prescription starts: a daily app built around the weekly routine. The prep checklist walks you through injection day. The medication graph helps you see the week at a glance. Injection-site rotation tracking helps you remember which side you used last. Side-effect logging covers 20 built-in symptoms with a 0–10 severity slider. Food logging works through five methods, including photo AI. It keeps food, symptoms, dose timing, and progress in one place instead of spread across memory, notes, and delivery emails. Goby's public pages do not show a comparable day-to-day tracking app, which is why MeAgain fits people who want more than intake and shipping.

MeAgain was built around what the GLP-1 week actually feels like: a shot day, a few days of appetite suppression, food choices that need more protein and fiber, and symptoms that can change from one dose to the next. That is different from both a generic calorie counter and a telehealth company whose public job is mostly intake, clinician review, and shipping. Inside MeAgain, dose timing, weight, food, water, steps, and side effects live in one place, so the routine feels easier to follow. Goby Meds may fit if you mainly want a straightforward prescription path. MeAgain fits better if you want the app you keep opening after the box arrives. That daily tracking is why people choose MeAgain after the first shipment arrives.

Goby's public pricing is better on starter packs. About $99/month for compounded semaglutide and $133/month for compounded tirzepatide is lower than MeAgain's all-in monthly cost at the beginning. The gap changes once dose needs rise. Goby's public monthly options move to about $169/month and $299/month, while MeAgain keeps the listed medication price flat plus the monthly app subscription. That means Goby can be the cheaper first-month trial, especially if you want a 12-week starter bundle. MeAgain becomes the cheaper long-term option at maintenance pricing, saving about $432 per year on semaglutide and about $1,080 per year on tirzepatide based on the verified fact sheet. That is the honest price story: Goby wins the entry tier, while MeAgain wins the flatter year-round math and includes the daily app.

The Capybara home screen widget gives MeAgain something most telehealth companies do not build: a reason to come back every day. Many MeAgain subscribers have made it part of their routine, and it tracks protein, fiber, water, and steps with a mood that shifts when you're low on protein, water, fiber, or activity. Capy, the in-app AI companion, learns your dose schedule, side-effect history, and goals so the app feels specific to your week instead of generic. Journey Cards turn milestone photos into visible progress markers you can revisit later. That difference matters after week two, when the question stops being how to order and starts being how to stay consistent. Goby's public pages do not show any comparable habit loop or home-screen layer. If Goby is the company you use to get the prescription, MeAgain is the app you use to live with it.
Goby Meds and MeAgain solve the same starting problem in different ways. Goby is a telehealth service with cheaper starter packs, free 2-day cold-pack shipping, and pricing that rises as people move up in dose. MeAgain pairs a daily GLP-1 app with flat medication pricing at every dose and a separate monthly app subscription. The long-term framing matters because GLP-1 treatment is usually measured over months, not one checkout screen: in STEP-1, semaglutide users lost 14.9% of body weight on average over 68 weeks (n=1,961), and in SURMOUNT-1, tirzepatide users lost 20.9% on average over 72 weeks (n=2,539). That is why long-run price and day-to-day support matter more here than a single starter-pack headline.
| Factor | Goby Meds | MeAgain |
|---|---|---|
| Medication type | Compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide |
| Pricing model | Tiered by dose tier | Flat at every dose |
| Semaglutide entry tier | ~$99/mo starter pack | $123/mo flat |
| Semaglutide maintenance dose | ~$169/mo monthly | $123/mo flat |
| Tirzepatide entry tier | ~$133/mo starter pack | $199/mo flat |
| Tirzepatide maintenance dose | ~$299/mo monthly | $199/mo flat |
| Monthly fee | None | $9.99/mo app subscription |
| Pharmacy sourcing | LegitScript-certified pharmacies | US-based 503A and 503B pharmacies |
| Shipping | Free 2-day cold-pack | 5–7 days, US compounding network |
| Daily GLP-1 tracking app | No daily GLP-1 tracking app shown publicly | Yes — purpose-built, 286K users |
| Shot day checklist | No | Yes — step-by-step prep workflow |
| Medication levels chart | No | Yes — medication graph |
| Capybara widget | No | Yes — home screen companion |
| Side effect tracking | No | Yes — severity slider, custom symptoms |
| GLP-1 tracking App Store rating | No public app-store listing verified | 4.8 stars, 15,000+ ratings |
We make money from our $9.99/month app subscription. That's it. Goby Meds keeps the starter month cheaper and offers a 12-week starter bundle, which can be a good fit if your main goal is the lowest entry price. MeAgain costs more all-in at the entry dose because the subscription pays for the app itself: the prep checklist, weekly medication graph, injection-site rotation tracking, side-effect logging, food logging, and the Capybara home screen widget. Once pricing moves to Goby's maintenance tiers, MeAgain becomes the cheaper long-term option on both semaglutide and tirzepatide while keeping the same listed medication price at every dose. If you only want the cheapest starter pack, Goby can fit better. If you want flatter long-term pricing plus a daily GLP-1 app, MeAgain is built for that job. Whichever medication a licensed clinician recommends, the tracker works the same way, and the in-app intake is available inside MeAgain for eligible subscribers.
This content is for informational purposes only and does not constitute medical advice. Pricing information is based on publicly available data as of April 2026 and may change. Always consult your doctor about GLP-1 medications.
Sources
People comparing Goby Meds and MeAgain are usually deciding whether they want the cheaper starter price or the stronger daily app once the prescription begins. As one App Store reviewer (FitIn2026, March 16, 2026) wrote: “This app is easy to use and a wonderful way to stay on target with your goals. I’m down over 27 pounds and would recommend to anyone interested in tracking their macros while on GLP-1’s.” That is where MeAgain fits best. It keeps shot-day prep, food, symptoms, and progress in one place, so the routine feels easier to follow after the first delivery arrives.
Goby Meds focuses on intake, clinician review, refrigerated shipping, and cheaper starter packs. MeAgain adds stronger day-to-day tracking tools: shot-day prep, side-effect logging, food logging across five methods, the Capybara home screen widget, and an in-app AI companion. Goby can fit the lowest starter-price shopper. MeAgain fits the person who wants the stronger day-to-day app.

“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”
Choose MeAgain if you want more than the prescription itself. Goby Meds is a real telehealth option with no monthly fee and cheaper starter pricing at about $99/month for compounded semaglutide and $133/month for compounded tirzepatide. MeAgain is built differently. It pairs flat medication pricing with a monthly app subscription that gives you the prep checklist, weekly medication graph, injection-site rotation tracking, side-effect logging, food logging, and the home screen widget. MeAgain is also used by 286,000 people and rated 4.8 stars across over 15,000 App Store ratings. Goby's public pages focus on intake, clinician review, and shipping. MeAgain adds stronger day-to-day tracking tools after the prescription starts. If you want the lowest starter price, Goby can fit better. If you want a better daily GLP-1 app and flatter long-term pricing once doses go up, MeAgain is the stronger choice.

Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.